Baudax Bio (OTCMKTS:BXRXV) Shares Down 18.1%
Baudax Bio (OTCMKTS:BXRXV) Shares Down 18.1%
Baudax Bio, Inc. (OTCMKTS:BXRXV – Get Rating) fell 18.1% on Tuesday . The stock traded as low as $4.51 and last traded at $4.51. 119,000 shares traded hands during trading, an increase of 124% from the average session volume of 53,220 shares. The stock had previously closed at $5.51.
Baudax Bio Stock Performance
The company's fifty day moving average price is $4.51.
See Also
- Get a free copy of the StockNews.com research report on Baudax Bio (BXRXV)
- 3 Hot Stocks The Analysts Are Buying
- Hertz Global Holding Could Be A Comfortable Ride In 2023
- Two Billionaires Are Rigging the Market. Here's How to Fight Back
- Should Investors Buy or Sell the Vaccinex Patent News?
- Take-Two Interactive Or Activision Blizzard: An Obvious Choice?
Receive News & Ratings for Baudax Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baudax Bio and related companies with MarketBeat.com's FREE daily email newsletter.
Baudax Bio, Inc. (OTCMKTS:BXRXV – Get Rating) fell 18.1% on Tuesday . The stock traded as low as $4.51 and last traded at $4.51. 119,000 shares traded hands during trading, an increase of 124% from the average session volume of 53,220 shares. The stock had previously closed at $5.51.
鮑達克斯生物公司(OTCMKTS:BXRXV — 獲得評分)週二下降了 18.1%。該股價低至 4.51 美元,最後成交價為 4.51 美元。在交易過程中交易了 119,000 股,較 53,220 股平均交易量上升 124%。該股票之前收盤價為 5.51 美元。
Baudax Bio Stock Performance
鮑達克斯生物股票表現
The company's fifty day moving average price is $4.51.
該公司的五十天移動平均價格為 4.51 美元。
See Also
另請參閱
- Get a free copy of the StockNews.com research report on Baudax Bio (BXRXV)
- 3 Hot Stocks The Analysts Are Buying
- Hertz Global Holding Could Be A Comfortable Ride In 2023
- Two Billionaires Are Rigging the Market. Here's How to Fight Back
- Should Investors Buy or Sell the Vaccinex Patent News?
- Take-Two Interactive Or Activision Blizzard: An Obvious Choice?
- 獲取有關巴達克斯生物研究報告的免費副本
- 分析師正在購買的 3 股熱門股票
- 赫茲全球控股在 2023 年可能是一個舒適的旅程
- 兩位億萬富翁正在索具市場。這是如何反擊
- 投資者應該購買還是出售 Vinacca 專利新聞?
- 兩個互動或動視暴雪:一個明顯的選擇?
Receive News & Ratings for Baudax Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baudax Bio and related companies with MarketBeat.com's FREE daily email newsletter.
接收巴達斯生物日報的新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Baudax Bio 及相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧